Passage Bio, ahead of initiating a phase 1/2 clinical study for its frontotemporal dementia gene therapy, entered into a collaboration with genetics service provider InformedDNA to provide no-cost genetic counseling and testing for adults who have been diagnosed by their physicians with the condition. FTD is a debilitating form of early onset ....